- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06370611
Early Remote Rehabilitation to Improve Health of the Elderly After Cardiac Surgery. (RECARD Trial) (RECARD)
Early REmote Rehabilitation to Improve Health of the Elderly After CARDiac Surgery. (RECARD Trial). A Bi-center, Prospective, Randomized, Open-label, Blinded Evaluation (PROBE) Trial
An increasing number of older patients undergo heart surgery. Despite seemingly successful outcomes, these vulnerable patients may face prolonged decreased functional capacity, reduced self-efficacy, and impaired quality of life after discharge. Early engagement in physical activity and education plays a key role in health and well-being after heart surgery The goal of this clinical trial is to evaluate the effectiveness of an app-based exercise program and weekly calls from a physiotherapist in the early stages after open heart surgery.
Eligible patients will be randomly assigned to either a control group receiving standard care or an intervention group, which will be introduced to an individually tailored exercise program as an addition to standard care.
Follow-up is planned with an out-patient visit six weeks after discharge and a telephone interview six months post-surgery.
All participants will undergo assessments at enrollment and during follow-up. Physical performance will be evaluated through physical tests. General well-being, quality of life, self-reported physical activity, and cost-effectiveness of the intervention will be assessed through questionnaires. Muscle health will be examined through blood sampling, CT scans, and muscle biopsies.
The primary endpoint is the 30-second Chair Stand Test serving as a measurement of physical function.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hypotheses:
Primary: Early mobile health intervention at home supplemented by weekly calls from a physiotherapist after cardiac surgery improves functional outcomes, exercise tolerance, and quality of life in older patients.
Secondary:
- Cardiac surgery increases the prevalence and extent of sarcopenia in the elderly which can be mitigated by early mobile health intervention
- Sarcopenia on Chest Computed Tomography (CCT) is strongly correlated to functional outcome and quality of life following cardiac surgery
- Early mobile health intervention is feasible and cost-effective
Design:
This is a bi-center, prospective, randomized controlled, parallel, two-arm, open-label, blinded evaluation (PROBE) trial with a superiority design. The study population will consist of a representative group (n=120) of older patients scheduled for open heart surgery who fulfill the requirements according to inclusion and exclusion criteria. The patients will be recruited from 2 cardiac surgery centers in northern and central Denmark.
Patients are stratified after center and subsequently randomly allocated (1:1) to receive mobile health intervention as an adjunct to standard care (Intervention Group), or standard care alone (Control group) for 6 weeks after discharge. Follow-up is planned with an outpatient visit 6 weeks after discharge, and a telephone interview 6 months after surgery.
Patients in the intervention group receive a 6-week home-based CR using the ICURA Activity app and sensor-based technology (ICURA ApS, Copenhagen, Denmark). During the hospital stay patients in the intervention group are introduced to the app's usage, and an individualized training plan is collaboratively created and subsequently tailored by a physiotherapist. The patients are equipped with a case including an ICURA Activity-sensor with a charger, an illustrative quick guide, and a contact telephone number. According to the patient's preference, the app is either installed on their own mobile phone or provided on a separate mobile device.
The comprehensive mobile health intervention includes customized training programs, activity tracking, visualization of exercises with videos, text message communication with patients, and a password-protected webpage for physiotherapists to customize training programs and track patient activity.
A few days after discharge, patients in the intervention group will receive the first call from the physiotherapist, to ensure, that the patient is using the ICURA app actively. The patients will receive two calls per week for the first two weeks and as required the following four weeks.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ivy S. Modrau, MD, dr.med.
- Phone Number: +45 24778856
- Email: ivymod@clin.au.dk
Study Contact Backup
- Name: Rikke Daugaard, PT, MHSc
- Phone Number: +45 41282266
- Email: daugaard@clin.au.dk
Study Locations
-
-
-
Aalborg, Denmark, 9000
- Aarlborg University Hospital
-
Contact:
- Stian Ingemann-Molden, PT, MHSc
- Phone Number: +45 97664210
- Email: s.ingemannmolden@rn.dk
-
Aarhus, Denmark, 8200
- Aarhus University Hospital
-
Contact:
- Rikke Daugaard, PT, MHSc
- Phone Number: +45 41282266
- Email: daugaard@clin.au.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Provision of signed and dated informed consent form
- Scheduled first-time heart surgery through median sternotomy
- Male or female, aged ≥ 65 years (The age criterion implies the exclusion of women of childbearing potential)
- Available Cardiac-CT (< 3 months)
Exclusion Criteria:
- Medical conditions requiring referral to specialized rehabilitation (e.g., severe heart or lung failure, need for blood pressure monitoring during exercise)
- Emergent procedure
- Anticipated inability to perform intervention, study assessment procedures, or follow-up
- Participation in any other interventional clinical that may interfere with the outcome measures
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Early mobile health intervention
ICURA Activity app and sensor-based technology, individualized training plan, and weekly calls from a physiotherapist in addition to standard care
|
Six-week home-based rehabilitation program using the ICURA Activity app and sensor-based technology (ICURA ApS, Copenhagen, Denmark). During the hospital stay patients in the intervention group are introduced to the app's usage, and an individualized training plan is collaboratively created and subsequently tailored by a physiotherapist. The comprehensive mobile health intervention includes customized training programs, activity tracking, visualization of exercises with videos, and a password-protected webpage for physiotherapists to customize training programs and track patient activity. The patients will receive two calls from a physiotherapist per week for the first two weeks and as required the following four weeks.
Other Names:
|
No Intervention: Control
Standard care consists of physiotherapy group education of about 10-15 minutes regarding mobilization, respiratory therapy, and sternal precautions after surgery.
After surgery, phase I in-hospital rehabilitation consists of respiratory therapy, mobilization from supine and sitting position, and walking down a corridor.
Prior to discharge, all patients are encouraged to undertake daily walks and resume activities of daily living, and engage in recommended moderate physical activity (Borg's scale 12-14).
All patients are referred to CR in their municipality.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change (Δ) 30-second chair stand test (30CST) baseline vs. 6-week FU
Time Frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Recording of the number of stands a person can complete from a chair without arms in 30 seconds
|
1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change (Δ) in 10-meter Walk Test (10MWT) baseline vs. 6-week FU
Time Frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Measurement of walking speed in meters per second over a 10-meter distance
|
1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Difference in 6-minute Walk Test (6MWT) between groups at 6-week FU
Time Frame: 6 weeks (+/- 4 days) after surgery
|
Measurement of walking distance in 6 minutes.
|
6 weeks (+/- 4 days) after surgery
|
Change (Δ) in WHO-5-score baseline vs. 6-week FU
Time Frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery and 6 months after surgery
|
5-item World Health Organization Well-Being Index (WHO-5), questionnaire assessing subjective well-being
|
1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery and 6 months after surgery
|
Change (Δ) in ASS-2-score baseline vs. 6-week FU
Time Frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery and 6 months after surgery
|
Anxiety Symptom Scale-2 (ASS-2), questionnaire assessing anxiety
|
1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery and 6 months after surgery
|
Change (Δ) in MDI-2-score baseline vs. 6-week FU
Time Frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery and 6 months after surgery
|
Major Depression Inventory-2 (MDI-2), questionnaire assessing depression
|
1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery and 6 months after surgery
|
Change (Δ) in Self-reported Physical Activity baseline vs. 6-week FU
Time Frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery and 6 months after surgery
|
Questionnaire assessing self-reported physical activity
|
1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery and 6 months after surgery
|
Change (Δ) in EuroQol-score baseline vs. 6-week FU
Time Frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery and 6 months after surgery
|
EuroQol-5-Dimension-5-Level Questionnaire (EQ-5D-5L), questionnaire assessing health-related quality of life
|
1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery and 6 months after surgery
|
Change in skeletal muscle mass maximum 3 months prior to surgery vs. 6-week FU
Time Frame: Maximum 3 months prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Body composition analysis with artificial-intelligence-assisted medical image analysis (CT scan) (DAFS©, Veronoi Health Analytics, Vancouver, Canada) to assess quantity and quality of skeletal muscle.
|
Maximum 3 months prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Cost-effectiveness analysis
Time Frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery and 6 months after surgery
|
Questionnaire assessing the cost-effectiveness of the intervention in comparison to usual care
|
1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery and 6 months after surgery
|
Changes in markers of musculoskeletal health through blood samples baseline vs. 6-week FU
Time Frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Markers of muscle health: Myoglobin, Creatine Kinase (CK)
|
1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Changes in markers of inflammation through blood samples baseline vs. 6-week FU
Time Frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Inflammatory markers: White Cell Count (WCC), Platelet Count, Mean Platelet Volume (MPV), Immature Platelet Fraction (IPF), High-Sensitive C-Reactive Protein (hs-CRP)
|
1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Changes in markers of nutrition through blood samples baseline vs. 6-week FU
Time Frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Nutritional markers: Hemoglobin, Glycated Hemoglobin (HbA1c), fasting glucose, Albumin, Triglycerides, High-Density Lipoprotein (HDL), Low-Density Lipoprotein (LDL), Vitamin B12, Folate, 25-OH-Vitamin D2+D3
|
1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Changes in markers of liver function through blood samples baseline vs. 6-week FU
Time Frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Liver Function Markers: Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT)
|
1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Changes in markers of kidney function through blood samples baseline vs. 6-week FU
Time Frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Kidney Function Markers: Creatinine, estimated Glomerular Filtration Rate (eGFR)
|
1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Changes in markers of hormone levels through blood samples baseline vs. 6-week FU
Time Frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Hormonal Markers: Cortisol, Free/Total Testosterone, Sex Hormone Binding Globulin (SHBG), Insulin-like Growth Factor-1 (IGF-1)
|
1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Ivy S. Modrau, MD, dr.med., Aarhus University Hospital
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2314027
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Rehabilitation
-
Mayo ClinicRecruitingCardiac RehabilitationUnited States
-
Defactum, Central Denmark RegionRecruiting
-
University of Central LancashireUniversity of Hull; Sheffield Hallam University; Leeds Beckett UniversityWithdrawnCardiac RehabilitationUnited Kingdom
-
University of North Carolina, Chapel HillNational Institutes of Health (NIH)CompletedCardiac RehabilitationUnited States
-
Texas A&M UniversityAscension HealthNot yet recruiting
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Jessa HospitalCompleted
-
The Cleveland ClinicCompleted
-
China National Center for Cardiovascular DiseasesNot yet recruiting
-
Mayo ClinicRecruitingCardiac RehabilitationUnited States